In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
COVID-19 and Cardiology Read more
 

Practice Guideline Track on Myocardial Revascularization 2014

Guidelines into Practice

Coronary Artery Disease (Chronic)
Cardiovascular Surgery
Acute Cardiac Care


Contributor:  Special thanks to Stuart Head from the Task Force on Myocardial Revascularization of ESC and EACTS, with contribution of EAPCI.

Based on the 2014 ESC/EACTS Guidelines in Myocardial Revascularisation.

Webinars on this topic

  2016 ESC General Cardiology webinar, "Myocardial revascularization : how have the guidelines changed our practice"  Watch the recording.

  2015 ESC General Cardiology webinar, the multidiscplinary heart team discussions on "Diabetic patient with stable angina"  Watch the recording.

Part 1 - Overview of the 2014 ESC/EACTS Guidelines on Myocardial Revascularization

Session Presentation Slides Webcast
ESC 2014 Guidelines overview Myocardial revascularization    

ESC/EACTS Guidelines on Myocardial Revasularization 

 Strength of a joint ESC/EACTS Task Force    
Risk assessment and patient information    
Revascularization in patients with stable coronary artery disease    
Revascularization in patients with coronary artery disease and associated conditions    
 

Antithrombotic therapy in patients undergoing revascularization		    
Take home messages for practitioners  Concluding remarks    
Coronary artery disease update 2014    
Meet the Guidelines
Task Force I 		  Myocardial revascularization  

 

 

Part 2: Topics in focus

Topic Session Title Slides Webcast
IMAGING Optimal non-invasive strategy to detect worsening and severe ischaemia    
High risk patients with stable angina. When coronary angiography should be the first choice    
SCAD Coronary artery bypass surgery is the best option    
A fractional flow reserve-guided PCI is a valid alternative    
Left main disease: the surgeon's view    
How to individualise the revascularisation treatment?    
Fractional flow reserve-guided PCI versus medical treatment in stable coronary disease: FAME 2 primary end-point data analysis    
 
NSTE-ACS		 Revascularization in high risk NSTEMI    
NSTEMI: cath lab now or later?    
STEMI Is there (still) a role for thrombectomy in STEMI    
STEMI: essential questions in primary PCI    
CARDIOGENIC SHOCK Primary PCI: culprit lesion or immediate complete reveascularization?    
Percutaneous support: when and how    
DIABETES Revascularization in diabetes patients: CABG versus PCI    
VALVE INTERVENTIONS More aortic stenosis than coronary artery disease    
Combined aortic stenosis and coronary artery disease: conclusions and general take home message    
REPEAT PROCEDURES Stent thrombosis and restenosis: what have we learned and where are we going?    
PCI Optical coherence tomography: just nice to have or mandatory?    
ANTITHROMBOTIC When to stop dual antiplatelet therapy after ACS - less is more?    
Early initiation of antiplatelet therapy - Recommendations and current practice    
Upstream versus intraprocedural antiplatelet therapy    
Pre-treatment with P2Y12 inhibitors in acute coronary syndrome. PRO and CONTRA    
Complete versus Lesion only Primary-PCI Trial (CvLPRIT): treat the infarct related artery only or all lesions.    
 Bivalirudin as anticoagulant in primary PCI - pros and cons    


About the ESC
Press and Media
Information
Follow us

         

 Contact us

© 2020 European Society of Cardiology. All rights reserved.